An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib. - Sooi, Kenneth; Danchaivijtr, Pongwut; Wong, C. K.; Tu, V. D.; Sachdeva, Manavi; Tai, B. C.; Soo, Ross A. (Thoracic Cancer, 2026)